Hikma Pharmaceuticals PLC (LSE:HIK) - Share price - Overview

Stock Report

Hikma Pharmaceuticals PLC HIK

Last Price
GBX1,717.50

Day Change
2.50|0.15%

As of 20/02/2019
08:10:30 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,715.00p
Day Range1,708.00 - 1,728.41
Mkt Cap4.14Bil
52-Wk Range814.20 - 2,089.00
Yield %0.00
ISINGB00B0LCW083
Volume1,573
P/E-420.75
P/S2.13
P/CF9.30

Share Price

Total Returns 19/02/2019

 Chg (%)  
More ...
Hikma Pharmaceuticals PLC10.82 
FTSE 100 TR GBP3.32
 
Financials
201520162017
More ...
Income Statement
Turnover1,440.001,950.001,936.00
Operating Profit409.00309.00323.00
Net Profit254.00158.00-839.00
Reported EPS1.250.66-3.51
Balance Sheet
Current Assets1,360.001,448.001,574.00
Non Current Assets1,237.002,915.001,814.00
Total Assets2,597.004,363.003,388.00
Current Liabilities592.00918.00797.00
Total Liabilities---
Total Equity1,352.002,411.001,528.00
Cash Flow
Operating Cash Flow366.00293.00443.00
Net Change in Cash281.00-383.0072.00

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/05/2018PurchaseMr. Sigurdur Olafsson1,309.1920,000261,838.00
22/05/2018PurchaseMr. John Julius Castellani1,376.951,00013,770.00
15/05/2018Exercise of OptionMr. Mazen Samih Taleb Darwazah0.0020,0000.00
15/05/2018Exercise of OptionMr. Said Darwazah0.0027,0000.00

Company Profile

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE 100 ,FTSE 350 ,FTSE All Share

Next Event 13/03/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)1.58
PEG (E)1.36
ROCE-26.52
Op Mrgn0.17
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Date06/04/1824/08/18
Ex-Div05/04/1823/08/18
Paid24/05/1821/09/18
Amnt16.009.40
Directors
More ...
Executive Director, Vice ChairmanMr. Mazen Samih Taleb Darwazah
Executive Director, ChairmanMr. Said Darwazah
Non-Executive DirectorMohammed Ali Khaldoun S Al-Husry
Non-Executive DirectorNina Henderson
Non-Executive DirectorMr. Patrick Butler
Non-Executive DirectorMr. John Julius Castellani
Non-Executive DirectorMr. Robert Pickering
Non-Executive DirectorDr. Ronald L Goode
Non-Executive DirectorDr. Pamela J Kirby
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.